Legacy effect of intensive glycaemic control in type 2 diabetes-the UKPDS

Rene Rodriguez-Gutierrez¹

Affiliations

Affiliation

¹ Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN 55905, USA; Endocrinology Division, University Hospital Dr José E González, Monterrey, Mexico; Plataforma INVEST Medicina-UANL-KER Unit, KER Unit Mexico, Universidad Autónoma de Nuevo León, Monterrey, Mexico. Electronic address: rodriguezgutierrez.rene@mayo.edu.

PMID: 39002982
DOI: 10.1016/S0140-6736(24)01395-3

Comment

Legacy effect of intensive glycaemic control in type 2 diabetes-the UKPDS

Rene Rodriguez-Gutierrez. Lancet. 2024.

. 2024 Jul 13;404(10448):100-102.

doi: 10.1016/S0140-6736(24)01395-3.

Author

Rene Rodriguez-Gutierrez¹

Affiliation

¹ Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN 55905, USA; Endocrinology Division, University Hospital Dr José E González, Monterrey, Mexico; Plataforma INVEST Medicina-UANL-KER Unit, KER Unit Mexico, Universidad Autónoma de Nuevo León, Monterrey, Mexico. Electronic address: rodriguezgutierrez.rene@mayo.edu.

PMID: 39002982
DOI: 10.1016/S0140-6736(24)01395-3

No abstract available

PubMed Disclaimer

Conflict of interest statement

I declare no competing interests.

Comment on

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
[No authors listed] [No authors listed] Lancet. 1998 Sep 12;352(9131):854-65. Lancet. 1998. PMID: 9742977 Clinical Trial.
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
Adler AI, Coleman RL, Leal J, Whiteley WN, Clarke P, Holman RR. Adler AI, et al. Lancet. 2024 Jul 13;404(10448):145-155. doi: 10.1016/S0140-6736(24)00537-3. Epub 2024 May 18. Lancet. 2024. PMID: 38772405 Clinical Trial.

References

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Legacy effect of intensive glycaemic control in type 2 diabetes-the UKPDS

Affiliation

Legacy effect of intensive glycaemic control in type 2 diabetes-the UKPDS

Author

Affiliation

Conflict of interest statement

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical